Lisdexamfetamine Dimesylate Capsule
Product Images NDC 42291-039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lisdexamfetamine Dimesylate (NDC 42291-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (036 90)

1 (036 90)
FDA Label Image

1 (037 90)

1 (037 90)
FDA Label Image

1 (038 90)

1 (038 90)
FDA Label Image

1 (039 90)

1 (039 90)
FDA Label Image

1 (040 90)

1 (040 90)
FDA Label Image

1 (041 90)

1 (041 90)
FDA Label Image

8c301747-figure-01 (Lisdexamfetamine Dimesylate Capsules 1)

8c301747-figure-01 (Lisdexamfetamine Dimesylate Capsules 1)
FDA Label Image

Figure 1 (Lisdexamfetamine Dimesylate Capsules 2)

Figure 1 (Lisdexamfetamine Dimesylate Capsules 2)
FDA Label Image

2 (Lisdexamfetamine Dimesylate Capsules 3)

2 (Lisdexamfetamine Dimesylate Capsules 3)
FDA Label Image

3 (Lisdexamfetamine Dimesylate Capsules 4)

3 (Lisdexamfetamine Dimesylate Capsules 4)
FDA Label Image

1 (Lisdexamfetamine Dimesylate Capsules 5)

1 (Lisdexamfetamine Dimesylate Capsules 5)
FDA Label Image

Figure 5 (Lisdexamfetamine Dimesylate Capsules 6)

Figure 5 (Lisdexamfetamine Dimesylate Capsules 6)
FDA Label Image

6 (Lisdexamfetamine Dimesylate Capsules 7)

6 (Lisdexamfetamine Dimesylate Capsules 7)
FDA Label Image

7 (Lisdexamfetamine Dimesylate Capsules 8)

7 (Lisdexamfetamine Dimesylate Capsules 8)
This text shows a graph with the title "Time (days after randomization)" and different data points. The data includes numbers such as "8" and percentages like "(%) 2iniies". Additionally, there are some unclear characters and symbols. This data may correspond to a study or experiment where measurements were taken over a period of days after randomization.*
FDA Label Image

Figure 8 (Lisdexamfetamine Dimesylate Capsules 9)

Figure 8 (Lisdexamfetamine Dimesylate Capsules 9)
This is a graph showing the proportion of subjects with relapse over time for those on Lisdexamfetamine dimesylate and Placebo in a clinical trial. The x-axis represents time in days after randomization, and the y-axis represents the percentage of subjects with relapse. The data suggests that Lisdexamfetamine dimesylate may have a lower relapse rate compared to the Placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.